Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Momenta Pharmaceuticals Inc (MNTA)
since 2014 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Momenta Pharmaceuticals Inc.
(See page 1 of this report.) Table 2 shows the detailed insider transactions.
This company's CIK number is 1235010.
Total stock buying since 2014: $0.
Total stock sales since 2014: $79,248,629.
Total stock option exercises since 2014: $27,019,701.
Table 3. Detailed insider trading at Momenta Pharmaceuticals Inc (MNTA) , Part 4
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2017-11-21 | Leicher Bruce (SVP & General Counsel) | Sale | 803 | 13.15 | 10,559 |
| 2017-11-21 | Kaundinya Ganesh Venkataraman (COO & CSO) | Sale | 821 | 13.15 | 10,796 |
| 2017-11-21 | Wheeler Craig A (President & CEO) | Sale | 4,116 | 13.35 | 54,928 |
| 2017-11-10 | Leicher Bruce (SVP & General Counsel) | Sale | 355 | 13.07 | 4,639 |
| 2017-11-10 | Kaundinya Ganesh Venkataraman (COO & CSO) | Sale | 392 | 13.12 | 5,143 |
| 2017-11-10 | Wheeler Craig A (President & CEO) | Sale | 1,852 | 13.25 | 24,539 |
| 2017-09-28 | Wheeler Craig A (President) | Sale | 35,667 | 19.02 | 678,564 |
| 2017-09-28 | Wheeler Craig A (President) | Option Ex | 25,667 | 7.41 | 190,192 |
| 2017-09-01 | Wheeler Craig A (President) | Sale | 14,617 | 17.00 | 248,489 |
| 2017-09-01 | Wheeler Craig A (President) | Option Ex | 14,167 | 7.41 | 104,977 |
| 2017-08-31 | Wheeler Craig A (President) | Sale | 5,750 | 17.00 | 97,750 |
| 2017-08-31 | Wheeler Craig A (President) | Option Ex | 2,300 | 7.41 | 17,043 |
| 2017-08-21 | Leicher Bruce (SVP & General Counsel) | Sale | 802 | 15.20 | 12,190 |
| 2017-08-21 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 821 | 15.20 | 12,479 |
| 2017-08-21 | Wheeler Craig A (President) | Sale | 4,116 | 15.06 | 62,007 |
| 2017-08-10 | Leicher Bruce (SVP & General Counsel) | Sale | 350 | 16.60 | 5,810 |
| 2017-08-10 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 387 | 16.60 | 6,424 |
| 2017-08-10 | Wheeler Craig A (President) | Sale | 16,953 | 16.82 | 285,200 |
| 2017-08-10 | Wheeler Craig A (President) | Option Ex | 9,100 | 7.41 | 67,431 |
| 2017-08-02 | Wheeler Craig A (President) | Sale | 200 | 17.00 | 3,400 |
| 2017-08-02 | Wheeler Craig A (President) | Option Ex | 100 | 7.41 | 741 |
| 2017-05-22 | Leicher Bruce (SVP & General Counsel) | Sale | 859 | 14.80 | 12,713 |
| 2017-05-19 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 821 | 15.90 | 13,053 |
| 2017-05-19 | Wheeler Craig A (President) | Sale | 4,116 | 15.83 | 65,156 |
| 2017-05-10 | Leicher Bruce (SVP & General Counsel) | Sale | 347 | 16.00 | 5,552 |
| 2017-05-10 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 384 | 16.00 | 6,144 |
| 2017-05-10 | Wheeler Craig A (President) | Sale | 1,852 | 15.77 | 29,206 |
| 2017-02-22 | Leicher Bruce (SVP & General Counsel) | Sale | 1,050 | 15.60 | 16,380 |
| 2017-02-22 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 1,069 | 15.60 | 16,676 |
| 2017-02-22 | Wheeler Craig A (President) | Sale | 5,626 | 15.51 | 87,259 |
| 2017-01-31 | Leicher Bruce (SVP & General Counsel) | Sale | 5,000 | 18.00 | 90,000 |
| 2017-01-09 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Option Ex | 39,647 | 10.11 | 400,831 |
| 2016-12-15 | Shea Richard P (SVP, CFO) | Sale | 9,799 | 15.00 | 146,985 |
| 2016-12-09 | Shea Richard P (SVP, CFO) | Sale | 1,451 | 15.00 | 21,765 |
| 2016-11-22 | Roach James M. (Senior VP, Development and Chi) | Sale | 250 | 14.40 | 3,600 |
| 2016-11-22 | Leicher Bruce (SVP & General Counsel) | Sale | 227 | 14.40 | 3,268 |
| 2016-11-22 | Shea Richard P (SVP, CFO) | Sale | 227 | 14.40 | 3,268 |
| 2016-11-22 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 227 | 14.40 | 3,268 |
| 2016-11-22 | Wheeler Craig A (President) | Sale | 1,764 | 14.05 | 24,784 |
| 2016-11-21 | Roach James M. (Senior VP, Development and Chi) | Sale | 841 | 13.45 | 11,311 |
| 2016-11-21 | Leicher Bruce (SVP & General Counsel) | Sale | 803 | 13.45 | 10,800 |
| 2016-11-21 | Shea Richard P (SVP, CFO) | Sale | 744 | 13.45 | 10,006 |
| 2016-11-21 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 821 | 13.45 | 11,042 |
| 2016-11-21 | Wheeler Craig A (President) | Sale | 4,116 | 13.52 | 55,648 |
| 2016-08-22 | Roach James M. (Senior VP, Development and Chi) | Sale | 249 | 12.10 | 3,012 |
| 2016-08-22 | Leicher Bruce (SVP & General Counsel) | Sale | 227 | 12.10 | 2,746 |
| 2016-08-22 | Shea Richard P (SVP, CFO) | Sale | 227 | 12.10 | 2,746 |
| 2016-08-22 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 227 | 12.10 | 2,746 |
| 2016-08-22 | Wheeler Craig A (President) | Sale | 1,764 | 12.00 | 21,168 |
| 2016-08-19 | Roach James M. (Senior VP, Development and Chi) | Sale | 842 | 12.04 | 10,137 |
| 2016-08-19 | Leicher Bruce (SVP & General Counsel) | Sale | 803 | 12.04 | 9,668 |
| 2016-08-19 | Shea Richard P (SVP, CFO) | Sale | 745 | 12.04 | 8,969 |
| 2016-08-19 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 822 | 12.04 | 9,896 |
| 2016-08-19 | Wheeler Craig A (President) | Sale | 4,116 | 12.04 | 49,536 |
| 2016-06-01 | Shapiro Bennett M | Sale | 5,200 | 13.00 | 67,600 |
| 2016-06-01 | Shapiro Bennett M | Option Ex | 5,200 | 12.90 | 67,080 |
| 2016-05-20 | Roach James M. (Senior VP, Development and Chi) | Sale | 250 | 10.11 | 2,527 |
| 2016-05-20 | Leicher Bruce (SVP & General Counsel) | Sale | 1,000 | 10.40 | 10,400 |
| 2016-05-20 | Shea Richard P (SVP, CFO) | Sale | 227 | 10.11 | 2,294 |
| 2016-05-20 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 227 | 10.11 | 2,294 |
| 2016-05-20 | Wheeler Craig A (President) | Sale | 1,764 | 10.13 | 17,869 |
| 2016-05-19 | Roach James M. (Senior VP, Development and Chi) | Sale | 842 | 10.20 | 8,588 |
| 2016-05-19 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 784 | 10.20 | 7,996 |
| 2016-05-19 | Shea Richard P (SVP, CFO) | Sale | 746 | 10.20 | 7,609 |
| 2016-05-19 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 823 | 10.20 | 8,394 |
| 2016-05-19 | Wheeler Craig A (President) | Sale | 4,116 | 10.20 | 41,983 |
| 2016-04-19 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 2,843 | 9.57 | 27,207 |
| 2016-02-23 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 102 | 9.80 | 999 |
| 2016-02-22 | Roach James M. (Senior VP, Development and Chi) | Sale | 250 | 9.65 | 2,412 |
| 2016-02-22 | Leicher Bruce (SVP & General Counsel) | Sale | 227 | 9.65 | 2,190 |
| 2016-02-22 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 1,095 | 9.68 | 10,618 |
| 2016-02-22 | Shea Richard P (SVP, CFO) | Sale | 227 | 9.65 | 2,190 |
| 2016-02-22 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 227 | 9.65 | 2,190 |
| 2016-02-22 | Wheeler Craig A (President) | Sale | 1,688 | 9.95 | 16,795 |
| 2016-02-19 | Roach James M. (Senior VP, Development and Chi) | Sale | 2,158 | 9.64 | 20,813 |
| 2016-02-19 | Leicher Bruce (SVP & General Counsel) | Sale | 2,000 | 9.64 | 19,290 |
| 2016-02-19 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 2,065 | 9.63 | 19,913 |
| 2016-02-19 | Shea Richard P (SVP, CFO) | Sale | 1,823 | 9.64 | 17,582 |
| 2016-02-19 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 2,138 | 9.64 | 20,621 |
| 2016-02-19 | Wheeler Craig A (President) | Sale | 9,844 | 9.36 | 92,139 |
| 2016-02-18 | Roach James M. (Senior VP, Development and Chi) | Sale | 272 | 10.49 | 2,853 |
| 2016-02-18 | Leicher Bruce (SVP & General Counsel) | Sale | 337 | 10.49 | 3,535 |
| 2016-02-18 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 272 | 10.49 | 2,853 |
| 2016-02-18 | Shea Richard P (SVP, CFO) | Sale | 183 | 10.49 | 1,919 |
| 2016-02-18 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 272 | 10.49 | 2,853 |
| 2016-02-17 | Wheeler Craig A (President) | Sale | 1,688 | 11.30 | 19,074 |
| 2016-02-09 | Roach James M. (Senior VP, Development and Chi) | Sale | 17,100 | .00 | 0 |
| 2015-12-11 | Franken Michael (President, Biosimilars Busines) | Sale | 520 | 15.84 | 8,236 |
| 2015-11-23 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 80 | 17.91 | 1,432 |
| 2015-11-20 | Roach James M. (Senior VP, Development and Chi) | Sale | 360 | 17.75 | 6,390 |
| 2015-11-20 | Leicher Bruce (SVP & General Counsel) | Sale | 328 | 17.75 | 5,822 |
| 2015-11-20 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 468 | 17.75 | 8,307 |
| 2015-11-20 | Shea Richard P (SVP, CFO) | Sale | 227 | 17.75 | 4,029 |
| 2015-11-20 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 227 | 17.75 | 4,029 |
| 2015-11-20 | Wheeler Craig A (President) | Sale | 1,766 | 17.86 | 31,540 |
| 2015-11-19 | Roach James M. (Senior VP, Development and Chi) | Sale | 603 | 18.17 | 10,956 |
| 2015-11-19 | Leicher Bruce (SVP & General Counsel) | Sale | 603 | 18.17 | 10,956 |
| 2015-11-19 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 574 | 18.17 | 10,429 |
| 2015-11-19 | Shea Richard P (SVP, CFO) | Sale | 397 | 18.17 | 7,213 |
| 2015-11-19 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 397 | 18.17 | 7,213 |
| 2015-11-19 | Wheeler Craig A (President) | Sale | 2,061 | 18.05 | 37,201 |
| 2015-11-18 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 76 | 17.70 | 1,345 |
| 2015-11-17 | Roach James M. (Senior VP, Development and Chi) | Sale | 312 | 17.65 | 5,506 |
| 2015-11-17 | Leicher Bruce (SVP & General Counsel) | Sale | 387 | 17.65 | 6,830 |
| 2015-11-17 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 312 | 17.65 | 5,506 |
| 2015-11-17 | Shea Richard P (SVP, CFO) | Sale | 145 | 17.65 | 2,559 |
| 2015-11-17 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 216 | 17.65 | 3,812 |
| 2015-11-17 | Wheeler Craig A (President) | Sale | 1,766 | 17.70 | 31,258 |
| 2015-11-05 | Wheeler Craig A (President) | Sale | 51,667 | 18.00 | 930,006 |
| 2015-11-05 | Wheeler Craig A (President) | Option Ex | 41,667 | 16.18 | 674,172 |
| 2015-09-11 | Franken Michael (President, Biosimilars Busines) | Sale | 513 | 18.92 | 9,705 |
| 2015-08-21 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 79 | 20.01 | 1,580 |
| 2015-08-20 | Roach James M. (Senior VP, Development and Chi) | Sale | 363 | 22.20 | 8,058 |
| 2015-08-20 | Leicher Bruce (SVP & General Counsel) | Sale | 330 | 22.20 | 7,326 |
| 2015-08-20 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 470 | 22.20 | 10,434 |
| 2015-08-20 | Shea Richard P (SVP, CFO) | Sale | 228 | 22.20 | 5,061 |
| 2015-08-20 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 228 | 22.20 | 5,061 |
| 2015-08-20 | Wheeler Craig A (President) | Sale | 1,766 | 22.28 | 39,346 |
| 2015-08-19 | Roach James M. (Senior VP, Development and Chi) | Sale | 7,011 | 22.05 | 154,592 |
| 2015-08-19 | Leicher Bruce (SVP & General Counsel) | Sale | 601 | 22.00 | 13,222 |
| 2015-08-19 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 573 | 22.00 | 12,606 |
| 2015-08-19 | Shea Richard P (SVP, CFO) | Sale | 396 | 22.00 | 8,712 |
| 2015-08-19 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 396 | 22.00 | 8,712 |
| 2015-08-19 | Wheeler Craig A (President) | Sale | 2,061 | 22.02 | 45,383 |
| 2015-08-18 | Roach James M. (Senior VP, Development and Chi) | Sale | 6,500 | 21.81 | 141,765 |
| 2015-08-18 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 2,916 | 21.90 | 63,860 |
| 2015-08-17 | Roach James M. (Senior VP, Development and Chi) | Sale | 312 | 21.67 | 6,761 |
| 2015-08-17 | Leicher Bruce (SVP & General Counsel) | Sale | 386 | 21.67 | 8,364 |
| 2015-08-17 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 312 | 21.67 | 6,761 |
| 2015-08-17 | Shea Richard P (SVP, CFO) | Sale | 144 | 21.67 | 3,120 |
| 2015-08-17 | Kaundinya Ganesh Venkataraman (Senior V.P., Research) | Sale | 216 | 21.67 | 4,680 |
| 2015-08-17 | Wheeler Craig A (President) | Sale | 1,766 | 21.77 | 38,445 |
| 2015-08-10 | Franken Michael (President, Biosimilars Busines) | Sale | 20,000 | 22.36 | 447,200 |
| 2015-08-10 | Franken Michael (President, Biosimilars Busines) | Option Ex | 20,000 | 17.23 | 344,600 |
| 2015-07-15 | Stoner Elizabeth | Sale | 4,570 | 22.35 | 102,139 |
| 2015-07-15 | Stoner Elizabeth | Option Ex | 6,667 | 7.82 | 52,135 |
| 2015-06-19 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 21,274 | 25.50 | 542,487 |
| 2015-06-19 | Bishop John E (Senior VP, Pharmaceutical Scie) | Option Ex | 21,274 | 15.44 | 328,470 |
| 2015-06-18 | Roach James M. (Senior VP, Development and Chi) | Sale | 25,000 | 23.70 | 592,500 |
| 2015-06-18 | Roach James M. (Senior VP, Development and Chi) | Option Ex | 25,000 | 7.41 | 185,250 |
| 2015-06-18 | Leicher Bruce (SVP & General Counsel) | Sale | 20,000 | 23.00 | 460,000 |
| 2015-06-18 | Leicher Bruce (SVP & General Counsel) | Option Ex | 20,000 | 15.12 | 302,400 |
| 2015-06-18 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 35,529 | 23.63 | 839,656 |
| 2015-06-18 | Bishop John E (Senior VP, Pharmaceutical Scie) | Option Ex | 24,529 | 12.92 | 316,914 |
| 2015-06-18 | Wheeler Craig A (President) | Sale | 155,000 | 24.16 | 3,745,575 |
| 2015-06-18 | Wheeler Craig A (President) | Option Ex | 125,000 | 16.18 | 2,022,500 |
| 2015-06-17 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 784 | 23.00 | 18,032 |
| 2015-06-17 | Bishop John E (Senior VP, Pharmaceutical Scie) | Option Ex | 784 | 12.58 | 9,862 |
| 2015-06-11 | Franken Michael (President, Biosimilars Busines) | Sale | 512 | 22.37 | 11,453 |
| 2015-06-04 | Wheeler Craig A (President) | Sale | 103,333 | 22.00 | 2,273,326 |
Insider trading activities including stock purchases, stock sales, and option exercises
of MNTA listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Momenta Pharmaceuticals Inc (symbol MNTA,
CIK number 1235010) see
the Securities and Exchange Commission (SEC) website.